Pillstats
Rx only · Injection, Powder, Lyophilized, For Solution · Intravenous

Daptomycin

Brands: Dapzura Rt · Daptomycin

21 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US40 NDCs
21 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATC
RxCUI (US)
US makers21 labelers
Packages52
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 40 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$5.39$10.79$16.18$21.58Jul 2025Apr 2026Jun 2026
$18.762
Latest avg · Jun 17, 2026
+40%
Since Jul 23, 2025
21
Active US suppliers
23%
Top-2 supplier share*

Who makes it21 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Sagent Pharmaceuticalsunknown6SUPPLYING
Hikma Pharmaceuticals USA Inc.unknown6SUPPLYING
Meitheal Pharmaceuticals Inc.unknown5SUPPLYING
Xellia Pharmaceuticals USA LLCunknown5SUPPLYING
BE Pharmaceuticals Inc.unknown3SUPPLYING
Civica, Inc.unknown3SUPPLYING
Accord Healthcare Inc.unknown3SUPPLYING
Dr.Reddy's laboratories Limitedunknown3SUPPLYING
Camber Pharmaceuticals, Inc.unknown3SUPPLYING
Hospira, Inc.unknown2SUPPLYING
Mylan Institutional LLCunknown2SUPPLYING
Fresenius Kabi USA, LLCunknown2SUPPLYING
NorthStar RxLLCunknown2SUPPLYING
Qilu Pharmaceutical Co. Ltd.unknown1SUPPLYING
Biocon Pharma Incunknown1SUPPLYING

+ 6 more labelers

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.